Articles

Page 7 of 19

Aetiologies and factors associated with mortality among HIV-infected patients at Taraba State Specialist Hospital, Jalingo, Nigeria

Authors: DR Dashe

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P221

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Trends in human papillomavirus (HPV) infection among HIV-positive women in the pre-HAART and HAART era in a Nigerian clinic

Authors: MO Onigbogi and OY Ojo

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P217

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma

Authors: A Cingolani, L Torti, C Pinnetti, K de Gaetano Donatil, R Murri, E Tacconelli, LM Larocca and L Teofili

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P215

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Relationship between dynamics of Epstein-Barr virus and immune activation in HIV-1 infected subjects in the HAART era

Authors: AM Cattelan, M Zanchetta, L Sasset, R Petrara, R Freguja, K Gianesin, MG Cecchetto, F Cremona and A De Rossi

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P213

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin

Authors: L Bhatti, S Shah and H Khanlou

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P211

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Efficacy and safety of therapy of chronic hepatitis B with telbivudine (LdT) in patients with HIV-infection without HAART

Authors: SP Tsarenko, AV Kravchenko, VG Kanestri and SL Maximov

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P209

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Effectiveness of pegylated interferon alfa plus HAART in HIV/HBV treatment-naïve coinfected patients

Authors: JA Mata-Marín, CI Arroyo-Anduiza, R Arias-Flores and JE Gaytán-Martínez

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P207

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?

Authors: L Martín-Carbonero, NI Rallón, JM Benito, E Poveda, J González-Lahoz and V Soriano

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P205

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial

Authors: V Sekar, G De La Rosa, T Van de Casteele, S Spinosa-Guzman, P Vis and RMW Hoetelmans

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P185

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV-infected patients

Authors: Y Zhang, A Owen, D Egan and SF Sarfo

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P183

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi

Authors: L Dickinson, M Chaponda, D Carr, JJ van Oosterhout, J Kumwenda, DG Lalloo, M Pirmohamed, R Heyderman and SH Khoo

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P181

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load

Authors: A Calcagno, MG Milia, A D'Avolio, P Ndayishimiyae, P Dusabimana, S Bonora, J Cusato, M Simiele, R Rostagno, M Siccardi, S Audagnotto, V Ghisetti and G Di Perri

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P179

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Therapeutic drug monitoring (TDM) of atazanavir in pregnancy

Authors: LJ Else, V Jackson, M Brennan, J Breiden, C Weldridge, S Coulter-Smith, DJ Back, SH Khoo and J Lambert

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P177

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
T-CD4+ cell count at the date of the HIV diagnosis

Authors: AR Domingues da Silva, J Mendez and R Sarmento e Castro

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P175

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Five-year outcomes of HAART at a non-governmental treatment center in Lima, Peru

Authors: N Castillo, C Agurto, C Benites and JA Hidalgo

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P173

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
A high occurrence of late presenters and missed HIV diagnosis in clinical care in Sweden

Authors: J Brännström, V Svedhem, A Yilmaz, A Blaxhult, S Wendahl and A Sönnerborg

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P169

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Lack of utility of phosphate serum monitoring in HIV-infected patients on a tenofovir-based antiretroviral regimen

Authors: P Wikman, P Safont, MJ Perez-Elías, A Moreno, F Dronda, S Moreno and JL Casado

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P150

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
High prevalence of the UGT1A1*28 variant in HIV-infected individuals in Greece

Authors: P Panagopoulos, D Paraskevis, V Sypsa, M Detsika, K Protopapas, V Sakka, G Poulakou, A Papadopoulos, G Petrikkos and A Hatzakis

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P146

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Haemoglobin and anaemia in the SMART study

Authors: A Mocroft, AR Lifson, G Touloumi, J Neuhaus, Z Fox, A Palfreeman, M Vjecha, S Hodder, S De Wit, JD Lundgren and AN Phillips

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P144

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Development of drug resistance among HIV-1 F1 sub-type patients with treatment failure

Authors: A Temereanca, CM Sultana, L Manolescu, C Vagu, C Grancea and S Ruta

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P142

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
HIV drug resistance in children with treatment failure to first-line regimens in Ho Chi Minh City, Vietnam

Authors: VTT Nhung, D Colby, TH Khanh, TT Viet, D Lu, HT Thuy, B An and LT Giang

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P140

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Is extended resistance to the historical antiretroviral drugs & drug classes still a risk factor for HIV progression?

Authors: M Zaccarelli, P Lorenzini, P Marconi, F Forbici, C Gori, P Sette, F Ceccherini-Silberstein, P Narciso, CF Perno and A Antinori

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P138

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens

Authors: AG Marcelin, C Charpentier, C Ferreira, M Wirden, C Lemarchand, D Descamps and V Calvez

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P136

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: results from a multicenter study

Authors: G Madeddu, V Soddu, E Ricci, T Quirino, B Menzaghi, C Bellacosa, C Grosso, S Melzi, L Valsecchi, M Franzetti, F Vichi, G Penco, A Di Biagbio, G Pellicanò, L Corsico, GVL De Socio…

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P111

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Continuing burden of HIV late presenters in the North East of England 2009

Authors: N Premchand, K Golds, PY Tan, I Bittiner, N Sanker and ELC Ong

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P107

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Prevalence and factors associated with severe vitamin D deficiency in HIV/hepatitis C co-infected patients

Authors: S Surah, A Samarawickrama, L Campbell, R Kulasegaram, F Post, M Fisher, B Peters and J Fox

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P103

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Prevalence of vitamin D deficiency: cross-sectional study of a hospital cohort of HIV-1 infected outpatients

Authors: M Cervero, V Alcázar, C García-La Calle, R Sanz and JL Agud

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P101

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients

Authors: J Macías, J Mallolas, LF López-Cortés, JA Cartón, P Domingo, S Moreno, JA Iribarren, K Neukam, A Rodrigo, MJ Jiménez-Expósito and JA Pineda

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P91

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Intracellular tenofovir-diphosphate accumulation in an HIV-infected patient with Fanconi syndrome and osteomalacia

Authors: ME Haverkort, BW van der Spek, PT Lips, WAT Slieker and W Bronsveld

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P87

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Kidney tubular function and serum phosphate levels in HIV-1-infected patients treated with tenofovir: preliminary results

Authors: P Grima, A Zizza, P Calabrese, R Chiavaroli, A Faraone, M Tana, MR Sodo, P Tundo and M Guido

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P83

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)

Authors: JM Rodriguez, M Delgado, P Viciana, MA Lopez-Ruz, M Leal, F Alcacer, E Deig, A Antela, E Pedrol and S Moreno

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P79

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Dietician-based approach to lipodystrophic syndrome: role of bioelectrical impedance analysis at week 12

Authors: G Orofino, M Guastavigna, P Martinoglio, D Penoncelli, D Demarie, M Tettoni, P Desiderato, R Di Frenna and C Zignin

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P77

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Treatment of HIV-2 infection: a retrospective study from a Portuguese center

Authors: N Marques, D Seixas, P Crespo, L Malcata, J Vaz, V Mota, C Morais, J Oliveira, V Duque, J Saraiva da Cunha and A Meliço-Silvestre

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P54

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Changes in cerebral function parameters in HIV-1 infected subjects undergoing a treatment simplification to darunavir/ritonavir

Authors: LJ Garvey, C Higgs, P Mohammed, M Nelson and A Winston

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P52

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Lopinavir/ritonavir monotherapy in clinical practice

Authors: A Caso, E Valencia, V Moreno, M Cervero, J Sanz and R Torres Perea

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P50

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting

Authors: S Bonora, A Calcagno, O Viganò, P Bigliano, S Rusconi, L Trentini, MC Tettoni, G Orofino, B Salassa, C Bramato, A D'Avolio, M Siccardi, E Colella, M Galli and G Di Perri

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P48

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Lopinavir to atazanavir or darunavir switch in HIV-1-infected patients with dyslipidemia: an observational study

Authors: G Le Moal, G Beraud, T Prazuck, L Hocqueloux, A Dupuis and N Venisse

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P46

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Vitamin D and HIV: shine a light

Authors: J Currier

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O42

Content type: Oral presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study

Authors: V Cooper, R Horne and J Ewan

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P42

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Cardiovascular risk assessment in persons with HIV in the developing world: comparing three risk equations in a cohort of HIV-infected Thais

Authors: N Edwards-Jackson, SJ Kerr, HV Tieu, J Ananworanich, SM Hammer, K Ruxrungtham, P Phanuphak and A Avihingsanon

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O40

Content type: Oral presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Highlights of the 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, London, November 2010

Authors: M Schambelan

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O38

Content type: Oral presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Adolescents with perinatally acquired HIV — coming your way

Authors: C Foster

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O36

Content type: Oral presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
How early to start: what do observational data suggest?

Authors: J Sterne

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O34

Content type: Oral presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Factors associated with treatment modification during the first year of contemporary HAART

Authors: N Martin, I Perez-Valero, B San Jose Valiente, M Mora, JI Bernardino-Serna, J Gonzalez, F Gaya, FX Zamora, JM Pena and JR Arribas

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P15

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients

Authors: C Caldas, P Andrade, C Azevedo, C Piñeiro, R Serrão, J Soares, R Marques and A Sarmento

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P13

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O125. Influence of amount and percentage of CXCR4-using virus in predicting week 48 responses to maraviroc in treatment-naïve patients

Authors: H Valdez, D Chapman, P Biswai, M Lewis, C Craig, J Heera, S Ellery, LC Swenson and PR Harrigan

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O11

Content type: Oral presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals

Authors: A Pereira, JP Lopes da Cruz, C Carvalho, C Gonçalves and F Antunes

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P11

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug

Authors: E Billaud, JM Lacombe, A Abgrall, J Ghosn, O Launay, JM Livrozet, JL Meynard, J Pavie and D Costagliola

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P9

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients

Authors: P Kumar, E DeJesus, G Huhn, L Sloan, F Garcia, C Small, H Edelstein, F Felizarta, R Hao, B Ha, B Stancil, L Ross, K Oie and K Pappa

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P7

Content type: Poster presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Why suppression of HIV replication does not always make everything better

Authors: M Lederman

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):K1

Content type: Keynote presentation

Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF

Articles

Journal of the International AIDS Society